leadforensics

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies. Find out more about cookies.

Click here to dismiss this banner

Upcoming PHARMA CONFERENCES

rss_Pharma.jpg

Past PHARMA CONFERENCES

7th Lyophilization Americas

7th Lyophilization Americas

15th - 16th October 2014, The Seaport Hotel, Boston, USA
Lyophilization has in the recent years become a successful commercial process because it allows greater storage stability for otherwise labile biomolecules. This provides a convenient storage and shippage format and following reconstitution, rapidly delivers the product in its original formulation, ready for use. Examples of products which are commonly preserved by the process of lyophilization include: pharmaceutical and biotechnology drug formulations, nutraceuticals, cosmeceuticals, vaccines, biomaterials, blood plasma, bacteria and other microorganisms.

...more details
4th Biobanking UK

4th Biobanking UK

20th - 21st June 2014, Thistle City Barbican, London, UK
Biobanks are facilities containing biospecimens that are linked with either genotypic, phenotypic or non-health data. The information stored in biobanks is generally coded, but potentially re-identifiable. This is to maintain data privacy, while ensuring that the sample and information can be tracked to the donors, when required.

...more details
Epigenetics UK

Epigenetics UK

21st - 22nd May 2014, Visiongain Conference Centre, London, UK
Constituting in one of the fastest growing sector of research and development, the niche of Epigenetics is one that has grown significantly and plays a very important role in this decade where cancer has prevailed. Epigenetics being the study of heritable changes to gene expression not caused by changes to the DNA sequence, the way that these changes occur is by mechanisms which cause these mutations ultimately expressed without altering the underlying DNA sequence.

...more details
3rd Cell-Based Assays UK

3rd Cell-Based Assays UK

6th - 7th February 2014, Thistle City Barbican, London, UK
Cell Based Assays (CBA) investigate the in vivo properties and effects of a drug molecule due to the cells ability to replicate normal processes that would occur in the body. With the cost of developing a new drug for market launch estimated to be over $1bn1, this method of drug testing has the potential to save pharmaceutical companies millions through “fail early” techniques. These allow companies to detect any adverse effects that may occur in human cells that may not have been detected in animal cells. This can limit the chances of a medication failing in late stage clinical testing.

...more details

You have successfully subscribed. Thank you.

An internal error has occurred. Please try again later.

close